CLINICAL_TRIALS
trial_result
· 2011-06-08
Clinical Trial Update: Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma [Phase 2]
Summary
A Phase 2 clinical trial evaluating Campath-1H (alemtuzumab) for adults with acute T-cell leukemia/lymphoma has completed, with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Acute T-Cell Leukemia-Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2011-06-08